Health secretary says jab made by US company’s subsidiary Janssen will play important role in British programme
A single-shot coronavirus vaccine from Johnson & Johnson has been approved for use in the UK.
The vaccine, developed by Johnson & Johnson’s pharmaceutical arm Janssen, has been shown to be 67% effective overall at preventing moderate to severe Covid-19, with studies suggesting it also offers complete protection from admission to hospital and death.
